AntagomiR-based treatment for T2D: MiRNA-1 decreases insulin sensitivity via down regulation of a regulator of insulin receptor, Caveolin-1, Genome-2-Bio-Medicine Discovery center (GBMD), 19/08/2014, 10.51 am
August 19, 2014Assigning new function to a known drug: Metformin, the widely used drug in the treatment of NIDDM, functions as a “radiosensitizer” in lung cancer via up regulation of its target gene Nrf2, 20/August/2014, 06.35 am
August 20, 2014